Literature DB >> 8435830

Transcatheter arterial infusion therapy combined with radical hysterectomy in the treatment of advanced cervical cancer.

Y Nagata1, T Ishigaki, K Okajima, K Fujiwara, T Kinashi, M Mitumori, N Ooya, Y Kitakabu, M Hiraoka, M Abe.   

Abstract

Two or three sessions of transcatheter arterial infusion (TAI) therapy were performed preoperatively in 13 patients with advanced cervical cancer (stage 3 or more). The efficacy of TAI was evaluated by tumor markers, magnetic resonance imaging (MRI), and postoperative histopathological examination. In all cases, tumor marker levels decreased after TAI therapy, and MRI also showed a decrease in the tumor size in 11/12 patients. The tumor tissue resected at radical hysterectomy showed no viable cancer cells in 6 patients, and no viable extrauterine cancer was detected in 5 more patients. Thus, TAI performed via both internal iliac arteries reduced both tumor size and extension to the parametrium, and it appears to have the potential to be an effective treatment modality for advanced cervical cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435830     DOI: 10.1007/bf02603031

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  11 in total

1.  Use of intra-arterial nitrogen mustard therapy in the treatment of cervical and vaginal cancer.

Authors:  J K CROMER; J C BATEMAN; G N BERRY; J M KENNELLY; C T KLOPP; L I PLATT
Journal:  Am J Obstet Gynecol       Date:  1952-03       Impact factor: 8.661

2.  Complications of uterine cervix carcinoma treatments: the problem of a uniform classification.

Authors:  P Sismondi; G Sinistrero; P Zola; T Volpe; R Ferraris; G L Castelli; M Giai
Journal:  Radiother Oncol       Date:  1989-01       Impact factor: 6.280

3.  Cis-platinum in advanced gynecologic malignancy.

Authors:  F B Stehman; S C Ballon; L D Lagasse; T P Chamorro; R C Donaldson; J A Roberts; L C Ford
Journal:  Gynecol Oncol       Date:  1979-06       Impact factor: 5.482

4.  Intraarterial cis-platinum in the management of squamous cell carcinoma of the uterine cervix.

Authors:  J A Carlson; R S Freedman; S Wallace; V P Chuang; J T Wharton; F N Rutledge
Journal:  Gynecol Oncol       Date:  1981-08       Impact factor: 5.482

5.  cis-Platinum in gynecologic cancer. II. Squamous cell carcinoma of the cervix.

Authors:  D J Hall; R Diasio; D R Goplerud
Journal:  Am J Obstet Gynecol       Date:  1981-10-01       Impact factor: 8.661

6.  Balloon-occluded arterial infusion therapy in the treatment of primary and recurrent gynecologic malignancies.

Authors:  Y Yamashita; M Takahashi; H Bussaka; Y Korogi; R Saito; K Miyazaki; S Fujisaki; H Okamura
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jul-Aug       Impact factor: 2.740

Review 7.  The role of cisplatin in the management of advanced squamous cell cancer of the cervix.

Authors:  D S Alberts; N Mason-Liddil
Journal:  Semin Oncol       Date:  1989-08       Impact factor: 4.929

8.  Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.

Authors:  T Thigpen; H Shingleton; H Homesley; L Lagasse; J Blessing
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

9.  Carcinoma of the cervix: staging with MR imaging.

Authors:  K Togashi; K Nishimura; T Sagoh; S Minami; S Noma; I Fujisawa; Y Nakano; J Konishi; H Ozasa; I Konishi
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

10.  Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.

Authors:  G Rosen; R C Marcove; B Caparros; A Nirenberg; C Kosloff; A G Huvos
Journal:  Cancer       Date:  1979-06       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.